Babao Dan attenuates hepatic fibrosis by inhibiting hepatic stellate cells activation and proliferation via TLR4 signaling pathway
Metrics: PDF 2166 views | HTML 1919 views | ?
Lei Liang1,2,*, Xue Yang1,*, Yang Yu1,3,*, Xiaoyong Li1,2, Yechen Wu1,2, Rongyu Shi1, Jinghua Jiang1, Lu Gao1, Fei Ye1, Qiudong Zhao1, Rong Li1, Lixin Wei1, Zhipeng Han1
1Tumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospital, the Second Military Medical University, Shanghai, China
2Medical College of Soochow University, Suzhou, China
3Department of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai, 200065, China
*These authors contributed equally to this work
Zhipeng Han, email: [email protected]
Lixin Wei, email: [email protected]
Keywords: hepatic fibrosis, hepatic stellate cells, chinese medicine, Babao Dan, toll-like receptor 4
Received: August 01, 2016 Accepted: October 12, 2016 Published: October 20, 2016
Babao Dan (BBD), a traditional Chinese medicine, has been widely used as a complementary and alternative medicine to treat chronic liver diseases. In this study, we aimed to observe the protective effect of BBD on rat hepatic fibrosis induced by diethylnitrosamine (DEN) and explore it possible mechanism. BBD was administrated while DEN was given. After eight weeks, values of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) indicated that BBD significantly protected liver from damaging by DEN and had no obvious side effect on normal rat livers. Meanwhile, BBD attenuated hepatic inflammation and fibrosis in DEN-induced rat livers through histopathological examination and hepatic hydroxyproline content. Furthermore, we found that BBD inhibited hepatic stellate cells activation and proliferation without altering the concentration of lipopolysaccharide (LPS) in portal vein. In vitro study, serum from BBD treated rats (BBD-serum) could also significantly suppress LPS-induced HSCs activation through TLR4/NF-κB pathway. In addition, BBD-serum also inhibited the proliferation of HSCs by regulating TLR4/ERK pathway. Our study demonstrated that BBD may provide a new therapy strategy of hepatic injury and hepatic fibrosis.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.